Chromosomal losses involving the short arm of chromosome 8 are frequent in
a variety of tumour types, including breast cancer, suggesting the presence
of one or more tumour suppressor genes in this region. In this study, we h
ave used 11 microsatellite markers to analyse loss of heterozygosity (LOH)
at chromosome 8p in 151 sporadic breast tumours and 50 tumours from subject
s carrying the BRCA2 999del5 mutation. Fifty percent of sporadic tumours co
mpared to 78% of BRCA2 linked tumours exhibit LOH at one or more markers at
8p showing that chromosome 8p alterations in breast tumours from BRCA2 999
del5 carriers are more pronounced than in sporadic breast tumours. The patt
ern of LOH is different in the two groups and a higher proportion of BRCA2
tumours have LOH in a large region of chromosome 8p. In the total patient m
aterial, LOH of 8p is associated with LOH at other chromosome regions, for
example, 1p, 3p, 6q, 7q, 9p, 11p, 13q, 17p, and 20q, but no association is
found between LOH at 8p and chromosome regions 11q, 16q, 17q, and 18q. Furt
hermore, an association is detected between LOH at 8p and positive node sta
tus, large tumour size, aneuploidy, and high S phase fraction. Breast cance
r patients with LOH at chromosome 8p have a worse prognosis than patients w
ithout this defect. Multivariate analysis suggests that LOH at 8p is an ind
ependent prognostic factor. We conclude that chromosome 8p carries a tumour
suppressor gene or genes, the loss of which results in growth advantage of
breast tumour cells, especially in carriers of the BRCA2 999del5 mutation.